Should the nonaromatizable androgen dihydrotestosterone be considered as an alternative to testosterone in the treatment of the andropause?

Wang, C.; Swerdloff, R.S.

Journal of Clinical Endocrinology and Metabolism 87(4): 1462-1466

2002


ISSN/ISBN: 0021-972X
PMID: 11932265
DOI: 10.1210/jcem.87.4.8488
Document Number: 259417

Document emailed within 0-6 h
Secure & encrypted payments